- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
March 8, 2021Robins Kaplan LLP Announces 2021 Executive Board
-
March 4, 2021Robins Kaplan Files Class Action Against Martin Shkreli and His Former Companies on Behalf of Blue Cross and Blue Shield of Minnesota
-
March 1, 2021Amy Churan Named an Insurance Trailblazer by National Law Journal
-
March, 9, 2021The New Frontier of Software License Disputes
-
March 9, 2021Health Care Antitrust under President Biden
-
March 11, 2021Youth Frontiers’ 2021 Geometry of a Leader Conference
-
Winter 2021Pro Bono Publico–For The Public Good
-
Winter 2021The Case for Charitable Giving
-
Winter 2021The Fictional Wealth Disputes That We Took In and Learned From in 2020
-
March 8, 2021Financial Daily Dose 3.8.2021 | Top Story: Senate Passes $1.9 Trillion Covid Relief Bill
-
March 5, 2021Financial Daily Dose 3.5.2021 | Top Story: Powell Tries to Sooth Jumpy Markets Fearing Weak Jobs Report
-
March 4, 2021Financial Daily Dose 3.4.2021 | Top Story: Google Shakes Up Digital Ad Industry by Phasing Out Web Tracking
Eric Lindenfeld Joins Robins Kaplan's Mass Tort Group
March 24, 2017
Robins Kaplan LLP recently welcomed Eric Lindenfeld to the firm’s Mass Tort Group, where he focuses his practice on representing individuals who have been harmed by defective pharmaceutical and medical device products. Lindenfeld has experience in all phases of mass tort litigation, including trial practice, motion practice, conducting depositions, and written discovery. He is admitted to practice in Minnesota and in the U.S. District Court, District of Minnesota.
Lindenfeld earned his law degree, with honors, from the University of Minnesota. While attending law school, he won awards for outstanding written advocacy in various moot court competitions. He has also authored several scholarly articles on cutting-edge and developing topics in mass tort litigation.
Lindenfeld’s publications have been widely cited by law professors and practitioners, including in the Law, Medicine & Medical Technology and the Food and Drug Administration casebooks.
Related Professionals
Eric M. Lindenfeld
Associate
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.